Suppr超能文献

冷冻保存的人骨髓CD34(+)细胞在年轻成年NSG小鼠中的持续植入

Sustained Engraftment of Cryopreserved Human Bone Marrow CD34(+) Cells in Young Adult NSG Mice.

作者信息

Wiekmeijer Anna-Sophia, Pike-Overzet Karin, Brugman Martijn H, Salvatori Daniela C F, Egeler R Maarten, Bredius Robbert G M, Fibbe Willem E, Staal Frank J T

机构信息

Department of Immunohematology and Blood Transfusion, Leiden University Medical Center , Leiden, The Netherlands .

Central Laboratory Animal Facility, Leiden University Medical Center , Leiden, The Netherlands .

出版信息

Biores Open Access. 2014 Jun 1;3(3):110-6. doi: 10.1089/biores.2014.0008.

Abstract

Hematopoietic stem cells (HSCs) are defined by their ability to repopulate the bone marrow of myeloablative conditioned and/or (lethally) irradiated recipients. To study the repopulating potential of human HSCs, murine models have been developed that rely on the use of immunodeficient mice that allow engraftment of human cells. The NSG xenograft model has emerged as the current standard for this purpose allowing for engraftment and study of human T cells. Here, we describe adaptations to the original NSG xenograft model that can be readily implemented. These adaptations encompass use of adult mice instead of newborns and a short ex vivo culture. This protocol results in robust and reproducible high levels of lympho-myeloid engraftment. Immunization of recipient mice with relevant antigen resulted in specific antibody formation, showing that both T cells and B cells were functional. In addition, bone marrow cells from primary recipients exhibited repopulating ability following transplantation into secondary recipients. Similar results were obtained with cryopreserved human bone marrow samples, thus circumventing the need for fresh cells and allowing the use of patient derived bio-bank samples. Our findings have implications for use of this model in fundamental stem cell research, immunological studies in vivo and preclinical evaluations for HSC transplantation, expansion, and genetic modification.

摘要

造血干细胞(HSCs)的定义是其能够重新填充经清髓预处理和/或(致死性)照射的受体的骨髓。为了研究人类造血干细胞的重新填充潜力,已开发出依赖使用允许人类细胞植入的免疫缺陷小鼠的小鼠模型。NSG异种移植模型已成为用于此目的的当前标准,可实现人类T细胞的植入和研究。在此,我们描述了对原始NSG异种移植模型的改进方法,这些改进易于实施。这些改进包括使用成年小鼠而非新生小鼠以及短时间的体外培养。该方案可实现强大且可重复的高水平淋巴-髓系植入。用相关抗原免疫受体小鼠可导致特异性抗体形成,表明T细胞和B细胞均具有功能。此外,来自初代受体的骨髓细胞在移植到二代受体后表现出重新填充能力。使用冷冻保存的人类骨髓样本也获得了类似结果,从而无需新鲜细胞,并允许使用患者来源的生物样本库样本。我们的研究结果对该模型在基础干细胞研究、体内免疫学研究以及造血干细胞移植、扩增和基因改造的临床前评估中的应用具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f681/4048975/a5bd6b0167f5/fig-1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验